Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 28% ± 9% | |
lung | 11 studies | 29% ± 11% | |
eye | 8 studies | 31% ± 15% | |
kidney | 7 studies | 26% ± 5% | |
intestine | 6 studies | 28% ± 13% | |
brain | 6 studies | 34% ± 12% | |
lymph node | 5 studies | 26% ± 4% | |
pancreas | 4 studies | 52% ± 12% | |
placenta | 4 studies | 26% ± 6% | |
bone marrow | 4 studies | 22% ± 4% | |
uterus | 4 studies | 30% ± 14% | |
breast | 4 studies | 25% ± 2% | |
liver | 4 studies | 33% ± 22% | |
prostate | 3 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6095.14 | 459 / 459 | 100% | 239.23 | 1118 / 1118 |
esophagus | 100% | 5751.13 | 1445 / 1445 | 100% | 181.01 | 183 / 183 |
lung | 100% | 5472.89 | 578 / 578 | 100% | 214.13 | 1155 / 1155 |
ovary | 100% | 4734.23 | 180 / 180 | 100% | 174.18 | 430 / 430 |
pancreas | 100% | 3515.12 | 328 / 328 | 100% | 142.62 | 178 / 178 |
stomach | 100% | 4450.89 | 359 / 359 | 100% | 182.04 | 286 / 286 |
uterus | 100% | 5066.37 | 170 / 170 | 100% | 194.92 | 459 / 459 |
brain | 100% | 5907.21 | 2640 / 2642 | 100% | 233.65 | 705 / 705 |
intestine | 100% | 5382.94 | 966 / 966 | 100% | 203.06 | 525 / 527 |
prostate | 100% | 4436.54 | 245 / 245 | 99% | 147.84 | 499 / 502 |
liver | 100% | 3445.56 | 226 / 226 | 99% | 103.39 | 403 / 406 |
bladder | 100% | 5658.90 | 21 / 21 | 99% | 184.29 | 500 / 504 |
thymus | 100% | 5438.98 | 653 / 653 | 99% | 169.45 | 600 / 605 |
skin | 100% | 7245.10 | 1809 / 1809 | 99% | 208.76 | 467 / 472 |
adrenal gland | 100% | 6957.14 | 258 / 258 | 99% | 210.31 | 227 / 230 |
kidney | 100% | 5668.88 | 89 / 89 | 99% | 149.70 | 889 / 901 |
adipose | 100% | 6648.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6526.47 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 159.43 | 29 / 29 |
muscle | 100% | 7899.09 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3760.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 186.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 59.90 | 1 / 1 |
heart | 97% | 5578.40 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 132.43 | 77 / 80 |
peripheral blood | 84% | 2995.92 | 777 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030182 | Biological process | neuron differentiation |
GO_0030277 | Biological process | maintenance of gastrointestinal epithelium |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0000387 | Biological process | spliceosomal snRNP assembly |
GO_0034719 | Cellular component | SMN-Sm protein complex |
GO_0005829 | Cellular component | cytosol |
GO_0032797 | Cellular component | SMN complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_1990447 | Molecular function | U2 snRNP binding |
GO_0005515 | Molecular function | protein binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | STRAP |
Protein name | Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD) Serine/threonine kinase receptor associated protein Serine-threonine kinase receptor-associated protein |
Synonyms | UNRIP MAWD |
Description | FUNCTION: The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate. Binding of snRNA inside 5Sm triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP. STRAP plays a role in the cellular distribution of the SMN complex. Negatively regulates TGF-beta signaling but positively regulates the PDPK1 kinase activity by enhancing its autophosphorylation and by significantly reducing the association of PDPK1 with 14-3-3 protein. . |
Accessions | F5H1G1 ENST00000538718.1 Q9Y3F4 ENST00000541731.1 ENST00000025399.10 [Q9Y3F4-2] H0YH33 ENST00000419869.7 [Q9Y3F4-1] |